bicalutamid-ratiopharm 50 mg filmtabletta
ratiopharm hungária kft. - bicalutamide -
calumid 50 mg filmtabletta
richter gedeon nyrt. - bicalutamide -
calumid 150 mg filmtabletta
richter gedeon nyrt. - bicalutamide -
lanbicamid 50 mg filmtabletta
g.l. pharma gmbh - bicalutamide -
bicalutamid-teva 50 mg filmtabletta
teva magyarország zrt. - bicalutamide -
bicalutamid amite 50 mg filmtabletta
amite-spring kft. - bicalutamide -
bicalutatam 150 mg filmtabletta
generics uk limited - bicalutamide -
sanotamid 50 mg filmtabletta
sanofi-aventis zrt. - bicalutamide -
sanotamid 150 mg filmtabletta
sanofi-aventis zrt. - bicalutamide -
xtandi
astellas pharma europe b.v. - enzalutamide - prosztatikus daganatok - endokrin terápia - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.